UnknownNot Applicable

Adoption of L-PZQ for Schistosomiasis by Endemic Counties - Social Science Research Study

Côte d’Ivoire, Kenya, Uganda225 participantsStarted 2021-12-01

Plain-language summary

Knowledge, acceptability and perception of paediatric schistosomiasis and its treatment will be explored through a social science-driven mixed-methods approach within three endemic countries: Kenya, Uganda and Côte d'Ivoire.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * within the targeted communities * all key informant groups as described * willing to participate voluntarily and to provide informed consent Exclusion Criteria: \- refusing to give informed consent, participating not voluntarily or their participation causing psycho-social distress or even harm to themselves or other community members

What they're measuring

Qualitative data analysis including self-reported information on knowledge, perception, and experience of schistosomiasis (treatment) and child health within families (Micro, Meso and Macro level)

Timeframe: 13.12.2021 -31.06.2022 + Second study wave in 2024

Semi-structured socio-demographic questionnaires (quantitative data) used to collect further data from parents/guardians of PSAC in the study (knowledge, perception and acceptability related to (pediatric) schistosomiasis)

Timeframe: 13.12.2021 -31.06.2022 + Second study wave in 2024

Trial details

NCT IDNCT05350462

SponsorTechnical University of Munich

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-03-31

View on ClinicalTrials.gov More Schistosomiasis in Children trials